Results of the U.S. Multicenter Pivotal Study of the HELEX Septal Occluder for Percutaneous Closure of Secundum Atrial Septal Defects
Thomas K. Jones, MD, FACC*,a,*,
Larry A. Latson, MD, FACC ,a,
Evan Zahn, MD, FACC ,a,
Craig E. Fleishman, MD, FACC ,
Joth Jacobson, MS¶,
Robert Vincent, MD, FACC||,
Kirk Kanter, MD|| Multicenter Pivotal Study of the HELEX Septal Occluder Investigators#
* Childrens Heart Center, Childrens Hospital and Regional Medical Center, Seattle, Washington
Department of Pediatric Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio
The Congenital Heart Institute, Miami Childrens Hospital, Miami, Florida
The Congenital Heart Institute, Arnold Palmer Childrens Hospital, Orlando, Florida
¶ Gore Medical Products, W. L. Gore & Associates, Inc., Flagstaff, Arizona
|| Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia.
# The Multicenter Pivotal Study of the Helex Septal Occluder Investigators are listed in the .

View larger version (82K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 The HELEX Septal Occluder Is Shown Attached to the Integral Delivery System
By partially extending the mandrel within the control catheter, the left and right atrial disks of the occluder can be shown in this image.
|
|
|